Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12510000rdf:typepubmed:Citationlld:pubmed
pubmed-article:12510000lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:12510000lifeskim:mentionsumls-concept:C0678607lld:lifeskim
pubmed-article:12510000lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:12510000lifeskim:mentionsumls-concept:C0008565lld:lifeskim
pubmed-article:12510000lifeskim:mentionsumls-concept:C0002313lld:lifeskim
pubmed-article:12510000pubmed:issue1lld:pubmed
pubmed-article:12510000pubmed:dateCreated2003-1-2lld:pubmed
pubmed-article:12510000pubmed:abstractTextThe major active form of human thrombin, alpha-thrombin, was analyzed by hydrophobic interaction high-performance liquid chromatography (HIC-HPLC). The chromatographic system included a polymeric phenyl column and elution was performed by a gradient, 2-0M sodium chloride (5-20 min). Total analysis time was 30 min per injection. By this method, a good resolution between alpha-thrombin and the proteolytically modified thrombin forms, beta- and gamma-thrombin, was obtained. In addition, the thrombin preforms, prothrombin, prethrombin 1, and prethrombin 2, were also resolved from alpha-thrombin in the system. The results from the HIC method were compared to those obtained from non-reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. By this high-resolution chromatographic method, the rapid analysis of purified alpha-thrombin is possible.lld:pubmed
pubmed-article:12510000pubmed:languageenglld:pubmed
pubmed-article:12510000pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12510000pubmed:citationSubsetIMlld:pubmed
pubmed-article:12510000pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12510000pubmed:statusMEDLINElld:pubmed
pubmed-article:12510000pubmed:monthJanlld:pubmed
pubmed-article:12510000pubmed:issn1046-5928lld:pubmed
pubmed-article:12510000pubmed:authorpubmed-author:KarlssonGöran...lld:pubmed
pubmed-article:12510000pubmed:issnTypePrintlld:pubmed
pubmed-article:12510000pubmed:volume27lld:pubmed
pubmed-article:12510000pubmed:ownerNLMlld:pubmed
pubmed-article:12510000pubmed:authorsCompleteYlld:pubmed
pubmed-article:12510000pubmed:pagination171-4lld:pubmed
pubmed-article:12510000pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:meshHeadingpubmed-meshheading:12510000...lld:pubmed
pubmed-article:12510000pubmed:year2003lld:pubmed
pubmed-article:12510000pubmed:articleTitleAnalysis of human alpha-thrombin by hydrophobic interaction high-performance liquid chromatography.lld:pubmed
pubmed-article:12510000pubmed:affiliationPlasma R&D, Octapharma AB, SE-112 75 Stockholm, Sweden. goran.karlsson@biovitrum.comlld:pubmed
pubmed-article:12510000pubmed:publicationTypeJournal Articlelld:pubmed